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Abstract. The aim of the study was to develop the method for collecting 
and processing scintigraphic data to determine myocardial flow reserve by 
using gamma-camera with a new type detector based on Cadmium Zinc 
Telluride (CZT). Sixteen coronary artery disease patients and nine healthy 
volunteers received cardiac dynamic single-photon emission computed 
tomography with technetium 99m methoxyisobutylisonitrile (99mTc-MIBI) 
at rest and during pharmacologic stress test. Data processing involved a 
formation of regions of interest from the left ventricular (LV) cavity and 
myocardial walls to build activity-time curves. Myocardial flow reserve 
index was determined as a quotient of two ratios of mean myocardial 
counts to area under a curve peak from LV cavity during stress test and at 
rest. Mean values of myocardial flow reserve index were 1.86 (1.59; 2.2) in 
group of healthy volunteers and 1.39 (1.12; 1.69) in patients with 
multivessel coronary artery disease. When the value of this index was less 
than 1.77, the method allowed for identification of multivessel disease with 
sensitivity and specificity of 81.8% and 66.7%, respectively. Standard 
myocardial perfusion scintigraphy in combination with the method of 
myocardial flow reserve index determination allows for increasing 
diagnostic significance of the scintigraphic approach for assessment of 
coronary microcirculation lesions in multivessel coronary artery disease. 
1 Introduction 
Coronary artery disease is currently number one cause of disability and mortality from 
cardiovascular diseases. According to estimates of the World Health Organization, 7.4 
million people had died of this pathology worldwide during the period from 2002 to 2012.  
Revascularization procedure is currently considered the efficacious method for 
treatment of this pathology. This method consists in recovery of coronary blood flow 
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 through coronary artery bypass surgery or through stent placements in coronary arteries [1]. 
According to the recommendations of the European Society of Cardiology, 50–90% 
coronary artery stenosis requires surgical restoration of blood flow only in case of verified 
ischemia which can be confirmed by determining fractional flow reserve. Stenosis is 
considered hemodynamically significant if the above mentioned index equals 0.8 and less 
[1]. An invasive nature of the procedure as well as a high cost of the supplies do not allow 
for widespread use of this approach in clinical practice.  
Positron emission computed tomography with 15O-labeled water ([15O]H2O) is 
considered gold standard for noninvasive assessment of myocardial flow reserve 
([15O]H2O) [2, 3]. However, this method requires available cyclotron and expensive 
diagnostic equipment in a clinic delivering these studies. All these factors along with short 
half-life time of 15O (122.2 s) also significantly limit wide distribution of this method in 
everyday clinical practice. According to recommendations of the European Society of 
Cardiologists regarding myocardial revascularization, single-photon emission computed 
tomography (SPECT) plays an important role in diagnosing ischemia of the myocardium 
with sensitivity and specificity of 90–91% and 75–84%, respectively [4]. It is worth 
mentioning that SPECT quite often gives false-negative results in patients with 
hemodynamically significant multivessel coronary artery disease showing the absence of 
significant stress-induced perfusion defects. Literature describes this phenomenon by term 
“balanced ischemia” where a uniform decrease in an indicator accumulation is observed 
over the entire left ventricular (LV) myocardium [5, 6]. One of the ways to diagnose 
balanced ischemia of the myocardium in multivessel coronary artery disease consists in an 
assessment of myocardial flow reserve [7, 8].  
With reference to the above, search for new methods for an assessment of this 
parameter is a relevant task of modern cardiology [9].  
Up to now, most scintigraphy works in this direction were performed by using gamma-
cameras with detectors based on sodium iodide which did not allow for acquiring dynamic 
data in a tomographic mode [2, 8]. Implementation of SPECT with detectors based on 
Cadmium Zinc Telluride (CZT) allows for overcoming technical constraints and opens up 
new opportunities for a radionuclide determination of myocardial flow reserve.  
The aim of this study was to determine the informativity of dynamic tomoscintigraphy 
of the myocardium in identifying multivessel coronary artery disease.  
2 Method of study 
To determine coronary reserve, we proposed to perform myocardial SPECT with 
technetium 99m methoxyisobutylisonitrile (99mTc-MIBI) at rest and during pharmacological 
stress test.  
2.1 Preparation  
Patients were recommended to abstain from caffeine-containing beverages and/or 
medications for twelve hours before the procedure. The last meal was taken not less than 
two hours before the study. Immediately before the study, intravenous catheter was placed 
in a median cubital vein of a subject.  
2.2 Study procedure 
A patient was accommodated in a supine position on the table of gamma-camera. For 
correct patient positioning relative to gamma-camera detectors, low-dose computed 
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 tomography (100 keV; 10 mA/s) in the anterior projection was performed. Distances from 
suprasternal notch and left anterior auxiliary line to the center of cardiac silhouette were 
measured on an acquired image and a mark was placed on patient’s body. Detectors of 
gamma-camera were positioned over the left ventricular (LV) area based on the acquired 
results [10].  
A scintigraphy study was performed in two stages (Figure 1). At stage 1, the passage of 
a bolus of radiopharmaceutical was recorded at rest. To achieve this, a bolus injection of 1 
mL of 99mTc-MIBI in a dose of 185 MBq was done through the intravenous peripheral 
catheter. Recording began 5 s before the injection of radiopharmaceutical. Scintigraphic 
images were registered in a dynamic tomographic list mode format (allowing for 
reconstruction of series of dynamic and static tomoscintigrams from native data sets) for 
360 s. This time was enough for registering the passage of radioactive indicator through 
cardiac chambers and its accumulation in the LV myocardium. Immediately after the 
completion of data acquisition, stage 2 began where the passage of a bolus of 
radiopharmaceutical was recorded during pharmacological stress test [10].  
Figure 1. Scheme of cardiac dynamic SPECT for determination of myocardial flow reserve. 
 
All scintigraphic studies were performed by using gamma-camera with CZT-based 
solid-state detectors (GE Discovery NM/CT 570 C) with adjustment to 99mTc photopeak 
(140 keV).  
Stress test with adenosine triphosphate (ATP) was performed according to standard 
protocol [3]. Adenosine triphosphate dose (140 μg/kg/min) was calculated individually 
depending on patient’s body weight. Adenosine triphosphate was administered with a 
mechanical infusion pump according to 4-min protocol (2-min ATP infusions before and 
after the injection of radiopharmaceutical). At pharmacological stress test peak at the end of 
minute 2 of ATP infusion, patient received 1 mL of radiopharmaceutical 99mTc-Technetril 
in a dose of 740 MBq. After that, the study continued according to the protocol identical to 
the one specified above. A fourfold increase in a dose of the indicator at stage 2 was 
necessary for leveling blood pool radioactivity after the preceding study.  
2.3 Image procession and myocardial flow reserve assessment  
Two series of axial images were formed from primary data by using dedicated software 
(GE Alcyone: Dynamic Analysis Tool). Series 1 comprised group of 64 dynamic 
tomoscintigrams with each frame duration of 2.2. s representative of the passage of a bolus 
of radiopharmaceutical through the LV cavity and through the LV myocardium from 
second 1 to second 150 of the study; series 2 comprised static tomoscintigrams from second 
150 to second 360 representative of the accumulation of radiopharmaceutical in the LV 
walls.  
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 The next stage of data processing consisted in building the activity-time curves used for 
myocardial flow reserve calculation. To achieve this, regions of interest from the LV cavity 
and the LV walls were formed on the series of static frames; activity-time plots were built 
based on the dynamic images for each region of interest: anterior, posterior, lateral walls, 
septum, and apex of the left ventricle. Based on the obtained plots, mean value of counts 
from each region of interest in the left ventricle as well as area under curve characterizing 
the passage of a bolus of radiopharmaceutical through LV cavity were determined. These 
calculations were performed twice: for study at rest and for study during pharmacological 
stress test. Myocardial flow reserve index (MFRI) was determined separately for each LV 
wall as follows:  
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 , 
where: MFRI is myocardial flow reserve index; С is number of counts from the LV 
myocardium during stress test;  is number of counts from the LV cavity during stress 
test; С is number of counts from the LV myocardium at rest;  is number of counts 
from the LV cavity at rest. 
2.4 Method approbation 
A total of 16 ischemic heart disease patients aged 67±5 year (13 men, 3 women) with 
multivessel coronary artery disease diagnosed based on results of invasive coronary 
angiography were examined with this method. Comparison group comprised nine healthy 
volunteers aged 25±4 years (7 men, 2 women). 
Procedure of myocardial flow reserve assessment was approved by the local ethics 
committee of the authors’ institute. All patients were informed in a written format regarding 
the goal and potential risks of the study and gave informed consent to perform it.  
2.5 Statistical analysis 
Statistical processing of the results was performed with SPSS 18.0 and MedCalc 12.1.14.0 
software. Obtained data were not normally distributed (based on Kolmogorov-Smirnov 
criterion) so data were presented as median and quartiles (Ме (Q25;Q75)). Significance of 
intergroup differences was assessed based on nonparametric Mann-Whitney test. To 
determine differential boundary (cut-off value) between study values in independent 
samples, ROC-analysis with building ROC-curves was performed. Values were considered 
statistically significant when p was < 0.05.  
3 Results 
Based on performed analysis, mean LV MFRI in patients with three-vessel coronary artery 
disease significantly differed from the corresponding value in healthy volunteers group (P < 
0.05): 1.39 (1.12; 1.69) and 1.86 (1.59; 2.2), respectively.  
Statistically significant decreases in MFRI values in group of patients with multivessel 
disease compared with the corresponding values in individuals free of coronary 
atherosclerosis were also found based on analysis of MFRI in separate regions of the left 
ventricle (Table 1). 
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 Table 1. Regional values of myocardial flow reserve. 
LV regions 
Regional values of myocardial flow reserve 
Ме (Q25-Q75) 
Group of patients with 
multivessel coronary 
artery disease  
Group of healthy 
volunteers 
p-level (Mann-
Whitney) 
Apex 1.3 (1.0–1.76) 1.83 (1.65–2.04) 0.03 
Lateral wall 1.54 (1.12–1.73) 2.13 (1.42–2.31) 0.01 
Anterior wall 1.27 (1.0–1.7) 1.65 (1.19–1.98) 0.02 
Septum 1.25 (0.93–1.77) 2.1 (1.76–2.2) 0.01 
 
The results of ROC-analysis demonstrated that MFRI value of 1.77 allowed for 
verification of three-vessel coronary artery disease with sensitivity of 81.8% and specificity 
of 66.7%. The area under ROC-curve was 0.79 (p < 0.05) suggesting high confidence of the 
method (Figure 2).  
 
Figure 2. ROC-curve representative of diagnostic capabilities of myocardial flow reserve index in 
detecting multivessel coronary artery disease.  
4 Conclusion 
Search for a simple and inexpensive method for an assessment of myocardial flow reserve 
is currently considered one of the main directions of state-of-the-art cardiology. In the 
present study, for the first time, sensitivity and specificity of cardiac dynamic stress SPECT 
in assessment of myocardial flow reserve were determined and had values of 81.8% and 
66.7%, respectively. Our results rank below compared with operating characteristics of 
positron emission tomography with 15O-labeled water whose sensitivity and specificity 
values are 95% and 100%, respectively [4]. It is caused by linear dependence of [15O]H2O 
extraction fraction on myocardial flow rate as well as by higher resolution power of 
positron emission tomography scanners. Data obtained in our study agree with the results of 
other research groups who showed principal feasibility of myocardial flow reserve 
assessment by the methods of dynamic SPECT [4, 6, 7] or planar scintigraphy [2] with high 
diagnostic accuracy values.  
Therefore, implementation of the present method into clinical practice and experimental 
research may contribute to in-depth study of myocardial microcirculation processes and 
will allow for more adequate identification of treatment tactics in coronary insufficiency.  
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